FB, AAPL Options, GOGO & Extended Watchlist

Facebook, Inc. FB – Options

On Wednesday, some of you may recall our interest in FB calls, as we stated “if the stock can break the $46 barrier… we’d be looking at in-the-money Calls like the 09/21 $45.50′s.” As you can see on the included chart, after seeing a low of .10, those contracts would go on to trade as high as .85 during yesterday’s session. That move was good for overnight gains in excess of 750%

With FB gapping up this morning and hitting new 52-week highs, we are going to want to continue giving our attention to the Calls. Of course, in the event that we see a reversal off of these substantial gains, we are going to be on the lookout for a dip-and-rip scenario, which could bring us even further gains with a properly timed bottom.


Apple, Inc. AAPL – Options

We’re also seeing a gap up in AAPL which is coinciding with the release of the latest versions of the iPhone 5(S/C), and with a sizable gap to fill on the chart, we could actually see AAPL go to $490 today. If it did approach that level, we’d be interested in the $480-485 Calls, which could provide us multi-bag gains.

Other than flipping the weekly Calls intraday, we might also want to consider contracts with later expiration dates if it appears AAPL is gaining a head of steam that would carry over into next week.


Gogo, Inc. GOGO

We first mentioned GOGO on Monday, and at the time the stock was trading as low as 14.79. Currently we are seeing the stock trading at 18.15 pre-market, (a gain of 23%) so this is another play that will be grabbing our attention today. For a big-board stock in this price range to see a gain of that magnitude inside of a week is nothing short of remarkable.

Gogo actually has an intriguing technology for providing super-standard Wi-Fi internet connections to airline passengers with in-flight data delivery speeds of up to 60Mbps. With the company just having announced that they will be bringing their products to North America in 2014 pending FAA approval, this is definitely a stock that we are going to want to put on our long-term watchlist, as we see how its story plays out.


Extended Watchlist:
FREE, CYCC, VRNM, ACRX, FU, PZG, RNA (Big gap-down, watching for bounce.)

Afternoon Updates & Watchlist

Axxess Pharma, Inc. AXXE

After appearing in this morning’s alert, AXXE traded as high as .459 before dipping back to .30, and has come back to .393 as of the time of this publication. From that bottom, it represents an opportunity for an intraday 31%. When added to the many swings that we’ve observed from this bouncy stock since we began following it, the cumulative gains add up to nearly 100%  Volatile stocks like these can be good for rapid gains if properly timed, and we’ve seen evidence of that in AXXE.

Today’s PR:


FreeSeas, Inc. FREE

We’d also like to include an update on FREE, which we recently began tracking on September 10th, when we stated that we were on the lookout for the “next areas of resistance to come at .33 and .38,”.

This afternoon we’re happy to report that yesterday’s trading broke the low barrier at .33. and today the stock punched through the .38-mark to hit a high of .50.

From the low following 09/10 (.2213), today’s high equates to a 126% increase in just over a week.


Extended Watchlist:
EXMT, RAD, DRYS, ZNGA, GOGO FB

AXXE | Axxess Pharma, Inc. & Extended Watchlist

Axxess Pharma, Inc. AXXE
We’re touching base with AXXE again this morning, as the company has made some exciting announcements over the past couple of days including the acquisition of assets previously belonging to Revive Bioscience Inc., a Canadian OTC healthcare company, a move that widens AXXE’s catalog of pharma products significantly. Even more exciting is the fact that Revive held the rights to several branded OTC products endorsed by professional athletes in many major American sports including the NFL, NHL, and more.

Additionally, in a PR from yesterday we learned that AXXE has also made an addition to an already strong management team, with the appointment of Robert Tallack, who will serve as VP of Sales and Marketing. You can read more in depth about both developments by clicking through the press links below, but first, we’re going to take a look at how the AXXE chart is faring via the following video:

Be sure to check out the Exclusive Interview our sister site, Stock Traders Talk, conducted with AXXE President Dr. Daniel Bagi last week:
AXXE Interview

You can also take a look at our initial report on the company:
AXXE Report



Extended Watchlist:
FREE, DRYS, GOGO, RAD